Neo-adjuvant hormones and anxiety in prostate cancer
Research type
Research Study
Full title
Neo-adjuvant hormones and prostate cancer: Evaluating anxiety prior to radical radiotherapy
IRAS ID
147140
Contact name
Heather Buchanan
Contact email
Sponsor organisation
The University of Nottingham
Research summary
Clinical experience suggests that prostate cancer patients receiving hormone treatment prior to radical (curative) radiotherapy are extremely anxious. However no research appears to have been undertaken to quantify anxiety in this context or to investigate possible causes. Therefore the current research aims to assess the extent to which patients receiving hormones prior to radical radiotherapy may be anxious, and to assess why this may be the case.
Patients diagnosed with prostate cancer, and attending Nottingham City Hospital for hormone treatment prior to radical radiotherapy, will be eligible to take part. However patients must have received no prior treatment for prostate cancer and must be English-speaking, with the ability to understand written and verbal English, and able to provide informed consent.
Patients will be asked to complete a small number of questionnaires assessing their anxiety (the Hospital Anxiety and Depression Scale and the Memorial Anxiety Scale for Prostate Cancer), and to take part in an optional interview to further understand the possible causes of any anxiety.REC name
London - Queen Square Research Ethics Committee
REC reference
14/LO/0249
Date of REC Opinion
5 Feb 2014
REC opinion
Favourable Opinion